Release Date: December 16, 2020
Expiration Date: December 16, 2022
Estimated Time of Completion: 1 hour and 45 minutes
Description
Medical Dermatology Therapy Update online series will provide a review of traditional therapeutics,
as well as
biologic and small-molecule therapies, as it applies to a range of important medical dermatologic
conditions. In
addition it includes an overview of the pathogenesis and diagnosis of various medical dermatologic
diseases.
The Rheum/Derm Overlap Diseases – Updates and Optimization of Medical Therapy
webcast will review the
following medical conditions: dermatomyositis, cutaneous lupus, fibrosing skin disease, and
cutaneous vasculitis.
Learning Objectives
- Describe how to diagnose and the different clinical manifestations of systemic
sclerosis.
- Describe the current state of the art treatment and investigational medications for
localized scleroderma and systemic sclerosis.
- List treatable complications and urgencies.
- Review the latest understanding of pathogenesis.
- Effectively diagnose dermatomyositis.
- Construct a plan for the evaluation of a patient diagnosed with dermatomyositis.
- Manage patients with cutaneous dermatomyositis.
- Review current standard of care therapeutics for the treatment of cutaneous lupus
erythematosus (LE).
- Review second line treatments for cutaneous LE.
- Become familiar with potential upcoming treatments and their supportive data.
Target Audience
These activities are directed to physicians and advanced practice clinicians in
dermatology, immunology, oncology, rheumatology, internal medicine, and other health
care professionals caring for patients with autoimmune, chronic inflammatory, and
advanced malignant diseases.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing
medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring
material for a maximum of 1.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their
participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the
American Osteopathic Association for Category 2 credit.
ABIM MOC: Successful completion of this CME activity, which includes
participation in the evaluation component,
enables the participant to earn up to 1.75 Medical Knowledge MOC points in the American
Board of Internal
Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn
MOC points equivalent to
the amount of CME credits claimed for the activity. It is the CME activity
provider's responsibility to submit
participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH
Faculty
Jeffrey Callen, MD
University of Louisville School of Medicine
Louisville, KY
Robert Lafyatis, MD
Professor of Medicine and the Thomas Medsger Professor in Arthritis Research
University of Pittsburgh School of Medicine
Pittsburgh, PA
Emily Littlejohn, DO, MPH
Department of Rheumatic and Immunologic Disease
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH
Robert Micheletti, MD
Assistant Professor of Dermatology and Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
CME Disclaimer
The information in this educational activity is provided for general medical education
purposes only and is not meant to substitute for the independent medical judgment of a
physician relative to diagnostic and treatment options of a specific patient's medical
condition. The viewpoints expressed in this CME activity are those of the
authors/faculty. They do not represent an endorsement by The Cleveland Clinic
Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision
made or action taken in reliance upon the information provided through this CME
activity.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for
Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing
Education requires resolution of all faculty conflicts of interest to ensure CME activities are free
of commercial bias.
The following faculty has indicated that he may have a relationship which, in the context of his
presentation, could be perceived as a potential conflict of interest:
| Anthony P. Fernandez, MD, PhD |
| |
AbbVie Pharmaceuticals
|
Consulting
Membership on advisory committee or review panels
Teaching and Speaking
|
| |
Celgene Corporation
|
Consulting
|
| |
Corbus Pharmaceuticals
|
Research / Independent Contractor
|
| |
Mallinckrodt Inc.
|
Consulting
Research / Independent Contractor
Teaching and Speaking
|
| |
Novartis
|
Consulting
Research / Independent Contractor
Teaching and Speaking
|
| |
Pfizer, Inc.
|
Research / Independent Contractor
|
| |
Roche Pharmaceuticals
|
Principal Investigator for a Phase III Clinical Trial
|
| |
UCB
|
Consulting
|
| Jeffrey Callen, MD |
| |
Abbvie Pharmaceuticals, Allergan, Amgen, CVS/Caremark, Celgene
Corporation, Genentech, Gilead Sciences, Inc., Glaxo Smith Kline, Johnson and Johnson, Merck
& Co, Inc., Novartis, Pfizer, Inc, Procter & Gamble
|
Ownership interest (stock, stock options)
|
| |
Elsevier
|
Royalties from Books
|
| |
UpToDate, Inc |
Editor and author
|
The following faculty has indicated she has no relationship which, in the context of her
presentation(s), could be perceived as a potential conflict of interest:
Robert Lafyatis, MD
Emily Littlejohn, DO, MPH
Robert Micheletti, MD
|
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
Amgen Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
This CME activity was produced by the Cleveland Clinic Foundation Center for
Continuing Education
and the Dermatology and Plastic Surgery Institute.
